KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Preferred Shares (2016 - 2020)

Historic Preferred Shares for Pfizer (PFE) over the last 12 years, with Q1 2020 value amounting to $17.0 million.

  • Pfizer's Preferred Shares fell 1052.63% to $17.0 million in Q1 2020 from the same period last year, while for Mar 2020 it was $17.0 million, marking a year-over-year decrease of 1052.63%. This contributed to the annual value of $17.0 million for FY2019, which is 1052.63% down from last year.
  • As of Q1 2020, Pfizer's Preferred Shares stood at $17.0 million, which was down 1052.63% from $17.0 million recorded in Q4 2019.
  • Over the past 5 years, Pfizer's Preferred Shares peaked at $26.0 million during Q2 2016, and registered a low of $17.0 million during Q4 2019.
  • Over the past 5 years, Pfizer's median Preferred Shares value was $21.0 million (recorded in 2017), while the average stood at $21.1 million.
  • Per our database at Business Quant, Pfizer's Preferred Shares crashed by 714.29% in 2016 and then crashed by 1304.35% in 2018.
  • Pfizer's Preferred Shares (Quarter) stood at $24.0 million in 2016, then decreased by 12.5% to $21.0 million in 2017, then dropped by 9.52% to $19.0 million in 2018, then fell by 10.53% to $17.0 million in 2019, then changed by 0.0% to $17.0 million in 2020.
  • Its Preferred Shares stands at $17.0 million for Q1 2020, versus $17.0 million for Q4 2019 and $18.0 million for Q3 2019.